IBDEI2XW ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46911,1,4,0)
;;=4^N40.0
;;^UTILITY(U,$J,358.3,46911,2)
;;=^5015689
;;^UTILITY(U,$J,358.3,46912,0)
;;=N41.0^^179^2339^2
;;^UTILITY(U,$J,358.3,46912,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46912,1,3,0)
;;=3^Acute prostatitis
;;^UTILITY(U,$J,358.3,46912,1,4,0)
;;=4^N41.0
;;^UTILITY(U,$J,358.3,46912,2)
;;=^259106
;;^UTILITY(U,$J,358.3,46913,0)
;;=N41.1^^179^2339^6
;;^UTILITY(U,$J,358.3,46913,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46913,1,3,0)
;;=3^Chronic prostatitis
;;^UTILITY(U,$J,358.3,46913,1,4,0)
;;=4^N41.1
;;^UTILITY(U,$J,358.3,46913,2)
;;=^186931
;;^UTILITY(U,$J,358.3,46914,0)
;;=N41.2^^179^2339^1
;;^UTILITY(U,$J,358.3,46914,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46914,1,3,0)
;;=3^Abscess of prostate
;;^UTILITY(U,$J,358.3,46914,1,4,0)
;;=4^N41.2
;;^UTILITY(U,$J,358.3,46914,2)
;;=^270416
;;^UTILITY(U,$J,358.3,46915,0)
;;=N40.2^^179^2339^9
;;^UTILITY(U,$J,358.3,46915,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46915,1,3,0)
;;=3^Nodular prostate w/o LUTS
;;^UTILITY(U,$J,358.3,46915,1,4,0)
;;=4^N40.2
;;^UTILITY(U,$J,358.3,46915,2)
;;=^5015691
;;^UTILITY(U,$J,358.3,46916,0)
;;=N40.3^^179^2339^8
;;^UTILITY(U,$J,358.3,46916,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46916,1,3,0)
;;=3^Nodular prostate w/ LUTS
;;^UTILITY(U,$J,358.3,46916,1,4,0)
;;=4^N40.3
;;^UTILITY(U,$J,358.3,46916,2)
;;=^5015692
;;^UTILITY(U,$J,358.3,46917,0)
;;=N40.1^^179^2339^3
;;^UTILITY(U,$J,358.3,46917,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46917,1,3,0)
;;=3^BPH (enlarged prostate) w/ LUTS
;;^UTILITY(U,$J,358.3,46917,1,4,0)
;;=4^N40.1
;;^UTILITY(U,$J,358.3,46917,2)
;;=^5015690
;;^UTILITY(U,$J,358.3,46918,0)
;;=Z12.5^^179^2339^11
;;^UTILITY(U,$J,358.3,46918,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46918,1,3,0)
;;=3^Screen for Malig Neop of Prostate
;;^UTILITY(U,$J,358.3,46918,1,4,0)
;;=4^Z12.5
;;^UTILITY(U,$J,358.3,46918,2)
;;=^5062688
;;^UTILITY(U,$J,358.3,46919,0)
;;=R97.20^^179^2339^7
;;^UTILITY(U,$J,358.3,46919,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46919,1,3,0)
;;=3^Elevated PSA
;;^UTILITY(U,$J,358.3,46919,1,4,0)
;;=4^R97.20
;;^UTILITY(U,$J,358.3,46919,2)
;;=^334262
;;^UTILITY(U,$J,358.3,46920,0)
;;=R97.21^^179^2339^10
;;^UTILITY(U,$J,358.3,46920,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46920,1,3,0)
;;=3^Rising PSA s/p Treatment for Prostate CA
;;^UTILITY(U,$J,358.3,46920,1,4,0)
;;=4^R97.21
;;^UTILITY(U,$J,358.3,46920,2)
;;=^5139228
;;^UTILITY(U,$J,358.3,46921,0)
;;=D29.21^^179^2340^2
;;^UTILITY(U,$J,358.3,46921,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46921,1,3,0)
;;=3^Benign neoplasm right testis
;;^UTILITY(U,$J,358.3,46921,1,4,0)
;;=4^D29.21
;;^UTILITY(U,$J,358.3,46921,2)
;;=^5002093
;;^UTILITY(U,$J,358.3,46922,0)
;;=D29.22^^179^2340^1
;;^UTILITY(U,$J,358.3,46922,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46922,1,3,0)
;;=3^Benign neoplasm left testis
;;^UTILITY(U,$J,358.3,46922,1,4,0)
;;=4^D29.22
;;^UTILITY(U,$J,358.3,46922,2)
;;=^5002094
;;^UTILITY(U,$J,358.3,46923,0)
;;=E29.1^^179^2340^16
;;^UTILITY(U,$J,358.3,46923,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46923,1,3,0)
;;=3^Testicular Hypofunction
;;^UTILITY(U,$J,358.3,46923,1,4,0)
;;=4^E29.1
;;^UTILITY(U,$J,358.3,46923,2)
;;=^5002754
;;^UTILITY(U,$J,358.3,46924,0)
;;=N43.3^^179^2340^9
;;^UTILITY(U,$J,358.3,46924,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2XW 3792 printed Dec 13, 2024@02:37:58 Page 2
IBDEI2XW ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46911,1,4,0)
+2 ;;=4^N40.0
+3 ;;^UTILITY(U,$J,358.3,46911,2)
+4 ;;=^5015689
+5 ;;^UTILITY(U,$J,358.3,46912,0)
+6 ;;=N41.0^^179^2339^2
+7 ;;^UTILITY(U,$J,358.3,46912,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,46912,1,3,0)
+10 ;;=3^Acute prostatitis
+11 ;;^UTILITY(U,$J,358.3,46912,1,4,0)
+12 ;;=4^N41.0
+13 ;;^UTILITY(U,$J,358.3,46912,2)
+14 ;;=^259106
+15 ;;^UTILITY(U,$J,358.3,46913,0)
+16 ;;=N41.1^^179^2339^6
+17 ;;^UTILITY(U,$J,358.3,46913,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,46913,1,3,0)
+20 ;;=3^Chronic prostatitis
+21 ;;^UTILITY(U,$J,358.3,46913,1,4,0)
+22 ;;=4^N41.1
+23 ;;^UTILITY(U,$J,358.3,46913,2)
+24 ;;=^186931
+25 ;;^UTILITY(U,$J,358.3,46914,0)
+26 ;;=N41.2^^179^2339^1
+27 ;;^UTILITY(U,$J,358.3,46914,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,46914,1,3,0)
+30 ;;=3^Abscess of prostate
+31 ;;^UTILITY(U,$J,358.3,46914,1,4,0)
+32 ;;=4^N41.2
+33 ;;^UTILITY(U,$J,358.3,46914,2)
+34 ;;=^270416
+35 ;;^UTILITY(U,$J,358.3,46915,0)
+36 ;;=N40.2^^179^2339^9
+37 ;;^UTILITY(U,$J,358.3,46915,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,46915,1,3,0)
+40 ;;=3^Nodular prostate w/o LUTS
+41 ;;^UTILITY(U,$J,358.3,46915,1,4,0)
+42 ;;=4^N40.2
+43 ;;^UTILITY(U,$J,358.3,46915,2)
+44 ;;=^5015691
+45 ;;^UTILITY(U,$J,358.3,46916,0)
+46 ;;=N40.3^^179^2339^8
+47 ;;^UTILITY(U,$J,358.3,46916,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,46916,1,3,0)
+50 ;;=3^Nodular prostate w/ LUTS
+51 ;;^UTILITY(U,$J,358.3,46916,1,4,0)
+52 ;;=4^N40.3
+53 ;;^UTILITY(U,$J,358.3,46916,2)
+54 ;;=^5015692
+55 ;;^UTILITY(U,$J,358.3,46917,0)
+56 ;;=N40.1^^179^2339^3
+57 ;;^UTILITY(U,$J,358.3,46917,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,46917,1,3,0)
+60 ;;=3^BPH (enlarged prostate) w/ LUTS
+61 ;;^UTILITY(U,$J,358.3,46917,1,4,0)
+62 ;;=4^N40.1
+63 ;;^UTILITY(U,$J,358.3,46917,2)
+64 ;;=^5015690
+65 ;;^UTILITY(U,$J,358.3,46918,0)
+66 ;;=Z12.5^^179^2339^11
+67 ;;^UTILITY(U,$J,358.3,46918,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,46918,1,3,0)
+70 ;;=3^Screen for Malig Neop of Prostate
+71 ;;^UTILITY(U,$J,358.3,46918,1,4,0)
+72 ;;=4^Z12.5
+73 ;;^UTILITY(U,$J,358.3,46918,2)
+74 ;;=^5062688
+75 ;;^UTILITY(U,$J,358.3,46919,0)
+76 ;;=R97.20^^179^2339^7
+77 ;;^UTILITY(U,$J,358.3,46919,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,46919,1,3,0)
+80 ;;=3^Elevated PSA
+81 ;;^UTILITY(U,$J,358.3,46919,1,4,0)
+82 ;;=4^R97.20
+83 ;;^UTILITY(U,$J,358.3,46919,2)
+84 ;;=^334262
+85 ;;^UTILITY(U,$J,358.3,46920,0)
+86 ;;=R97.21^^179^2339^10
+87 ;;^UTILITY(U,$J,358.3,46920,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,46920,1,3,0)
+90 ;;=3^Rising PSA s/p Treatment for Prostate CA
+91 ;;^UTILITY(U,$J,358.3,46920,1,4,0)
+92 ;;=4^R97.21
+93 ;;^UTILITY(U,$J,358.3,46920,2)
+94 ;;=^5139228
+95 ;;^UTILITY(U,$J,358.3,46921,0)
+96 ;;=D29.21^^179^2340^2
+97 ;;^UTILITY(U,$J,358.3,46921,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,46921,1,3,0)
+100 ;;=3^Benign neoplasm right testis
+101 ;;^UTILITY(U,$J,358.3,46921,1,4,0)
+102 ;;=4^D29.21
+103 ;;^UTILITY(U,$J,358.3,46921,2)
+104 ;;=^5002093
+105 ;;^UTILITY(U,$J,358.3,46922,0)
+106 ;;=D29.22^^179^2340^1
+107 ;;^UTILITY(U,$J,358.3,46922,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,46922,1,3,0)
+110 ;;=3^Benign neoplasm left testis
+111 ;;^UTILITY(U,$J,358.3,46922,1,4,0)
+112 ;;=4^D29.22
+113 ;;^UTILITY(U,$J,358.3,46922,2)
+114 ;;=^5002094
+115 ;;^UTILITY(U,$J,358.3,46923,0)
+116 ;;=E29.1^^179^2340^16
+117 ;;^UTILITY(U,$J,358.3,46923,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,46923,1,3,0)
+120 ;;=3^Testicular Hypofunction
+121 ;;^UTILITY(U,$J,358.3,46923,1,4,0)
+122 ;;=4^E29.1
+123 ;;^UTILITY(U,$J,358.3,46923,2)
+124 ;;=^5002754
+125 ;;^UTILITY(U,$J,358.3,46924,0)
+126 ;;=N43.3^^179^2340^9
+127 ;;^UTILITY(U,$J,358.3,46924,1,0)
+128 ;;=^358.31IA^4^2
